In an article discussing how the COVID-19 pandemic has affected cancer clinical trials, Charles Blanke, M.D., says that following this outbreak, clinical researchers will be better prepared, and the increased emphasis on and capacity for virtual visits will be a lasting boon to both researchers and patients.
Mary and Ryan Finley donate $3 million to Legacy Health, OHSU to combat COVID-19. Danny Jacobs, M.D., M.P.H., FACS, says, “Philanthropy is critical during this health crisis, as it allows our health care systems to collaborate in assessing and prioritizing the greatest needs in managing the pandemic as it evolves."
Timur Mitin, M.D., joins a team of radiation oncologist who recommend a new framework for making decisions about radiational therapy for patients with prostate cancer.